Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
Open | $16.710 |
Close | - |
Volume / Avg. | 206.856K / 273.426K |
Day Range | 16.500 - 17.760 |
52 Wk Range | 8.080 - 41.450 |
Market Cap | $371.393M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 11.11% |
Days to Cover | 7.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enanta Pharma (NASDAQ: ENTA) through any online brokerage.
Other companies in Enanta Pharma’s space includes: Humacyte (NASDAQ:HUMA), Adverum Biotechnologies (NASDAQ:ADVM), Precigen (NASDAQ:PGEN), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
The latest price target for Enanta Pharma (NASDAQ: ENTA) was reported by JP Morgan on Thursday, February 8, 2024. The analyst firm set a price target for 11.00 expecting ENTA to fall to within 12 months (a possible -33.41% downside). 16 analyst firms have reported ratings in the last year.
The stock price for Enanta Pharma (NASDAQ: ENTA) is $16.52 last updated March 27, 2024 at 5:04 PM EDT.
There are no upcoming dividends for Enanta Pharma.
Enanta Pharma’s Q2 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Enanta Pharma.
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.